002349 精华制药
已收盘 11-12 15:00:00
资讯
新帖
简况
股市必读：精华制药（002349）11月6日披露最新机构调研信息
证券之星 · 11-09
股市必读：精华制药（002349）11月6日披露最新机构调研信息
精华制药：10月30日召开业绩说明会，投资者参与
证券之星 · 10-30
精华制药：10月30日召开业绩说明会，投资者参与
精华制药(002349)9月30日股东户数9.83万户，较上期增加28.52%
证券之星 · 10-27
精华制药(002349)9月30日股东户数9.83万户，较上期增加28.52%
股市必读：精华制药新发布《第六届董事会第十六次会议决议公告》
证券之星 · 10-27
股市必读：精华制药新发布《第六届董事会第十六次会议决议公告》
图解精华制药三季报：第三季度单季净利润同比增长17.18%
证券之星 · 10-27
图解精华制药三季报：第三季度单季净利润同比增长17.18%
精华制药（002349）披露关于延期出售参股子公司剩余股权的议案，10月26日股价下跌2.02%
证券之星 · 10-26
精华制药（002349）披露关于延期出售参股子公司剩余股权的议案，10月26日股价下跌2.02%
股市必读：精华制药（002349）10月22日董秘有最新回复
证券之星 · 10-23
股市必读：精华制药（002349）10月22日董秘有最新回复
精华制药：股东 邹智国投资者于10月19日调研我司
证券之星 · 10-19
精华制药：股东 邹智国投资者于10月19日调研我司
股市必读：精华制药新发布《关于完成工商变更登记并换发营业执照的公告》
证券之星 · 10-19
股市必读：精华制药新发布《关于完成工商变更登记并换发营业执照的公告》
精华制药（002349）10月14日主力资金净卖出5541.52万元
证券之星 · 10-15
精华制药（002349）10月14日主力资金净卖出5541.52万元
精华制药（002349）10月9日主力资金净买入1790.40万元
证券之星 · 10-12
精华制药（002349）10月9日主力资金净买入1790.40万元
精华制药(002349.SZ)：季德胜蛇药片新增带状疱疹适应症获药物临床试验批准
智通财经 · 10-11
精华制药(002349.SZ)：季德胜蛇药片新增带状疱疹适应症获药物临床试验批准
精华制药（002349）10月8日主力资金净卖出1384.48万元
证券之星 · 10-09
精华制药（002349）10月8日主力资金净卖出1384.48万元
股市必读：精华制药新发布《关于孙公司获得化学原料药上市申请批准通知书的公告》
证券之星 · 10-09
股市必读：精华制药新发布《关于孙公司获得化学原料药上市申请批准通知书的公告》
精华制药（002349）9月29日主力资金净卖出1826.00万元
证券之星 · 09-30
精华制药（002349）9月29日主力资金净卖出1826.00万元
异动快报：精华制药（002349）9月21日9点56分触及涨停板
证券之星 · 09-21
异动快报：精华制药（002349）9月21日9点56分触及涨停板
精华制药：外敷水凝胶已完成小试工作
证券之星 · 09-18
精华制药：外敷水凝胶已完成小试工作
股市必读：精华制药（002349）9月11日董秘有最新回复
证券之星 · 09-14
股市必读：精华制药（002349）9月11日董秘有最新回复
精华制药：公司目前暂未生产该产品
证券之星 · 09-11
精华制药：公司目前暂未生产该产品
股市必读：精华制药新发布《关于公司董事辞职的公告》
证券之星 · 09-11
股市必读：精华制药新发布《关于公司董事辞职的公告》
加载更多
公司概况
公司名称：
精华制药集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-02-03
主营业务：
精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。
发行价格：
19.80
{"stockData":{"symbol":"002349","market":"SZ","secType":"STK","nameCN":"精华制药","latestPrice":7,"timestamp":1794467019000,"preClose":7.06,"halted":0,"volume":20295289,"delay":0,"changeRate":-0.0085,"floatShares":814000000,"shares":831000000,"eps":0.28,"marketStatus":"已收盘","change":-0.06,"latestTime":"11-12 15:00:00","open":7.04,"high":7.12,"low":6.99,"amount":143000000,"amplitude":0.0184,"askPrice":7.01,"askSize":378,"bidPrice":7,"bidSize":663,"shortable":0,"etf":0,"ttmEps":0.28,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":7.06,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":7.77,"lowLimit":6.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":831069008,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":25,"roe":"6.67%","epsLYR":0.2678,"committee":0.560159,"marketValue":5817000000,"turnoverRate":0.0249,"status":1,"floatMarketCap":5699000000},"requestUrl":"/m/hq/s/002349","defaultTab":"news","newsList":[{"id":"2682082585","title":"股市必读：精华制药（002349）11月6日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2682082585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682082585?lang=zh_cn&edition=full","pubTime":"2026-11-09 01:09","pubTimestamp":1794157749,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘，精华制药报收于6.94元，下跌2.66%，换手率2.88%，成交量23.45万手，成交额1.63亿元。季德胜蛇药片处方与工艺属国家绝密级，2025年列入《毒蛇咬伤中医诊疗指南》及《带状疱疹中西医结合诊疗专家共识》，新增带状疱疹适应症已获国家药品监督管理局药物临床试验批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900000328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679621262","title":"精华制药：10月30日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2679621262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679621262?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:03","pubTimestamp":1793365428,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年10月30日精华制药发布公告称公司于2026年10月30日召开业绩说明会。精华制药2026年三季报显示，前三季度公司主营收入11.1亿元，同比上升1.6%；归母净利润1.9亿元，同比上升7.56%；扣非净利润1.82亿元，同比上升7.08%；其中2026年第三季度，公司单季度主营收入3.55亿元，同比下降1.63%；单季度归母净利润5358.28万元，同比上升17.18%；单季度扣非净利润5055.69万元，同比上升16.25%；负债率10.3%，投资收益216.49万元，财务费用-1150.32万元，毛利率53.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000055395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175897","title":"精华制药(002349)9月30日股东户数9.83万户，较上期增加28.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175897?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:42","pubTimestamp":1793097766,"startTime":"0","endTime":"0","summary":"证券之星消息，近日精华制药披露，截至2026年9月30日公司股东户数为9.83万户，较6月30日增加2.18万户，增幅为28.52%。在中药行业个股中，精华制药股东户数高于行业平均水平，截至9月30日，中药行业平均股东户数为5.24万户。从股价来看，2026年6月30日至2026年9月30日，精华制药区间涨幅为37.68%，在此期间股东户数增加2.18万户，增幅为28.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678863111","title":"股市必读：精华制药新发布《第六届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678863111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678863111?lang=zh_cn&edition=full","pubTime":"2026-10-27 04:30","pubTimestamp":1793046632,"startTime":"0","endTime":"0","summary":"公司公告汇总第六届董事会第十六次会议决议公告精华制药集团股份有限公司于2026年10月23日召开第六届董事会第十六次会议，审议通过《2026年第三季度报告》和《关于延期出售参股子公司剩余股权的议案》。会议应出席董事8名，实际出席8名，表决结果均为8票赞成，0票反对，0票弃权。公司持有江苏德礼生物13.26%股权，经与王烽及其指定第三方协商，签署《补充协议》，将原定股权出售交易延期至2026年底。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700006228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678182841","title":"图解精华制药三季报：第三季度单季净利润同比增长17.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678182841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678182841?lang=zh_cn&edition=full","pubTime":"2026-10-27 01:45","pubTimestamp":1793036719,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药2026年三季报显示，前三季度公司主营收入11.1亿元，同比上升1.6%；归母净利润1.9亿元，同比上升7.56%；扣非净利润1.82亿元，同比上升7.08%；其中2026年第三季度，公司单季度主营收入3.55亿元，同比下降1.63%；单季度归母净利润5358.28万元，同比上升17.18%；单季度扣非净利润5055.69万元，同比上升16.25%；负债率10.3%，投资收益216.49万元，财务费用-1150.32万元，毛利率53.19%。财报数据概要请见下图:本文数据来源于精华制药2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678194922","title":"精华制药（002349）披露关于延期出售参股子公司剩余股权的议案，10月26日股价下跌2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678194922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678194922?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:44","pubTimestamp":1793025861,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘，精华制药报收于7.27元，较前一交易日下跌2.02%，最新总市值为60.42亿元。该股当日开盘7.35元，最高7.36元，最低7.22元，成交额达1.66亿元，换手率为2.79%。公告显示，公司于2026年10月23日召开第六届董事会第十六次会议，审议通过《关于延期出售参股子公司剩余股权的议案》。根据公告，公司持有江苏德礼生物13.26%股权，经与王烽及其指定第三方协商，签署《补充协议》，将原定股权出售交易延期至2026年底。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600038059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677398998","title":"股市必读：精华制药（002349）10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677398998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677398998?lang=zh_cn&edition=full","pubTime":"2026-10-23 01:29","pubTimestamp":1792690151,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，精华制药报收于7.35元，下跌4.92%，换手率5.07%，成交量41.32万手，成交额3.09亿元。董秘最新回复投资者： 董秘您好，请问截至10月20日公司股东人数是多少？当日关注点交易信息汇总：10月22日主力资金净流出2090.68万元，占总成交额6.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300001812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676021215","title":"精华制药：股东 邹智国投资者于10月19日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2676021215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676021215?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:01","pubTimestamp":1792404075,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年10月19日精华制药发布公告称股东 邹智国于2026年10月19日调研我司。公司季德胜蛇药片新增带状疱疹适应症已获得国家药品监督管理局药物临床试验批准。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900023321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676757369","title":"股市必读：精华制药新发布《关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676757369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676757369?lang=zh_cn&edition=full","pubTime":"2026-10-19 03:09","pubTimestamp":1792350551,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，精华制药报收于8.05元，上涨1.9%，换手率8.07%，成交量65.71万手，成交额5.36亿元。交易信息汇总资金流向10月16日主力资金净流出272.69万元，占总成交额0.51%；游资资金净流出633.81万元，占总成交额1.18%；散户资金净流入906.5万元，占总成交额1.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675798303","title":"精华制药（002349）10月14日主力资金净卖出5541.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675798303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675798303?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:11","pubTimestamp":1792026691,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，精华制药报收于7.81元，下跌9.82%，换手率9.76%，成交量79.45万手，成交额6.37亿元。10月14日的资金流向数据方面，主力资金净流出5541.52万元，占总成交额8.7%，游资资金净流出298.44万元，占总成交额0.47%，散户资金净流入5839.95万元，占总成交额9.16%。融券方面，融券卖出7900.0股，融券偿还0.0股，融券余量6.01万股，融券余额46.94万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674473858","title":"精华制药（002349）10月9日主力资金净买入1790.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674473858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674473858?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:05","pubTimestamp":1791767137,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，精华制药报收于9.24元，上涨5.96%，换手率16.22%，成交量132.05万手，成交额12.19亿元。10月9日的资金流向数据方面，主力资金净流入1790.4万元，占总成交额1.47%，游资资金净流出300.14万元，占总成交额0.25%，散户资金净流出1490.26万元，占总成交额1.22%。近5日资金流向一览见下表：精华制药融资融券信息显示，融资方面，当日融资买入1.16亿元，融资偿还1.05亿元，融资净买入1064.38万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200002852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674481233","title":"精华制药(002349.SZ)：季德胜蛇药片新增带状疱疹适应症获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2674481233","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674481233?lang=zh_cn&edition=full","pubTime":"2026-10-11 17:04","pubTimestamp":1791709463,"startTime":"0","endTime":"0","summary":"智通财经APP讯，精华制药(002349.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》(受理号：CXZL2600062;通知书编号： 2026LP03037)，公司季德胜蛇药片增加功能主治用于带状疱疹(肝胆湿热证)的临床试验申请获得批准。季德胜蛇药片为公司现有已上市品种，本次获批事项系已上市中药品种增加功能主治的临床试验申请获得批准，不会对公司当期经营业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","PSYK","002349","IBBQ","BK0239","IBBJ","BMED","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881181","title":"精华制药（002349）10月8日主力资金净卖出1384.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674881181?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:09","pubTimestamp":1791508185,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，精华制药报收于8.72元，上涨1.99%，换手率11.43%，成交量93.05万手，成交额8.2亿元。10月8日的资金流向数据方面，主力资金净流出1384.48万元，占总成交额1.69%，游资资金净流入1688.39万元，占总成交额2.06%，散户资金净流出303.91万元，占总成交额0.37%。融券方面，融券卖出0.0股，融券偿还5800.0股，融券余量4.46万股，融券余额38.89万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674001101","title":"股市必读：精华制药新发布《关于孙公司获得化学原料药上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674001101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674001101?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:10","pubTimestamp":1791479423,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，精华制药报收于8.72元，上涨1.99%，换手率11.43%，成交量93.05万手，成交额8.2亿元。当日关注点交易信息汇总：10月8日主力资金净流出1384.48万元，占总成交额1.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900001492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002349","BK0239","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671422627","title":"精华制药（002349）9月29日主力资金净卖出1826.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671422627","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671422627?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:11","pubTimestamp":1790730718,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，精华制药报收于8.37元，下跌3.57%，换手率7.68%，成交量62.57万手，成交额5.33亿元。9月29日的资金流向数据方面，主力资金净流出1826.0万元，占总成交额3.43%，游资资金净流入2045.6万元，占总成交额3.84%，散户资金净流出219.59万元，占总成交额0.41%。融券方面，融券卖出1300.0股，融券偿还0.0股，融券余量4.62万股，融券余额38.67万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669139336","title":"异动快报：精华制药（002349）9月21日9点56分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669139336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669139336?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:01","pubTimestamp":1789956082,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，9点56分精华制药（002349）触及涨停板。其所属行业中药目前上涨。领涨股为精华制药。该股为PD-1抑制剂，流感，化学原料药概念热股，当日PD-1抑制剂概念上涨3.3%，流感概念上涨2.82%，化学原料药概念上涨2.22%。9月18日的资金流向数据方面，主力资金净流出640.17万元，占总成交额1.18%，游资资金净流出1275.25万元，占总成交额2.35%，散户资金净流入1915.42万元，占总成交额3.54%。近5日资金流向一览见下表：精华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100004710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668847943","title":"精华制药：外敷水凝胶已完成小试工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2668847943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668847943?lang=zh_cn&edition=full","pubTime":"2026-09-18 15:03","pubTimestamp":1789714990,"startTime":"0","endTime":"0","summary":"投资者提问：建议公司对季德胜蛇药片进行剂型改革，推出一些外用膏剂水剂型季德胜蛇药产品精华制药回复：您好，公司已围绕外用剂型开展了一系列研发布局：外敷水凝胶已完成小试工作，该产品利用水凝胶作为药物缓释和生物活性物质递送的载体，联合季德胜蛇药片等产品外敷治疗带状疱疹等疾病，旨在为片剂外用提供更便利的使用方式与更好的体验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800018290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667870086","title":"股市必读：精华制药（002349）9月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2667870086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667870086?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:12","pubTimestamp":1789319532,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，精华制药报收于8.01元，下跌5.88%，换手率10.91%，成交量88.79万手，成交额7.14亿元。董秘最新回复投资者： 董秘您好，查阅公开药品信息，公司持有盐酸多西环素片注册文号，该药品说明书注明可作为青霉素过敏患者部分感染的替代治疗用药。当日关注点交易信息汇总：9月11日主力资金净流出2440.11万元，占总成交额3.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0102","002349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666635541","title":"精华制药：公司目前暂未生产该产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2666635541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666635541?lang=zh_cn&edition=full","pubTime":"2026-09-11 15:03","pubTimestamp":1789110193,"startTime":"0","endTime":"0","summary":"证券之星消息，精华制药(002349)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，查阅公开药品信息，公司持有盐酸多西环素片注册文号，该药品说明书注明可作为青霉素过敏患者部分感染的替代治疗用药。请问该产品目前是否正常生产？谢谢。精华制药回复：公司目前暂未生产该产品，感谢您对公司的关心！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100028352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","002349","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666220597","title":"股市必读：精华制药新发布《关于公司董事辞职的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666220597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666220597?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:22","pubTimestamp":1789060935,"startTime":"0","endTime":"0","summary":"公司公告汇总关于公司董事辞职的公告精华制药集团股份有限公司收到第六届董事会成员曹伟东先生书面辞职报告。曹伟东先生因个人职业规划原因，申请辞去公司非独立董事职务，辞职后不再担任公司及子公司任何职务。关于股票交易异常波动的公告精华制药集团股份有限公司股票于2026年9月8日、9月9日连续两个交易日收盘价格涨幅偏离值累计超过20%，构成异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002349","BK0102"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794468124406,"stockEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.1645},{"period":"3month","weight":-0.0028},{"period":"6month","weight":-0.0054},{"period":"1year","weight":-0.1049},{"period":"ytd","weight":-0.0149}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.0627},{"period":"6month","weight":-0.11},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0726}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"精华制药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"98297人(较上一季度增加28.52%)","perCapita":"8282股","listingDate":"2010-02-03","address":"江苏省南通市崇川区港闸经济开发区兴泰路9号","registeredCapital":"83106万元","survey":" 精华制药集团股份有限公司的主营业务是传统中成药制剂、化学原料药及中间体、化工医药中间体、中药材及中药饮片、大健康产品等的研发、生产和销售。公司的主要产品是王氏保赤丸、季德胜蛇药片、正柴胡饮颗粒、黄芪泡腾片、当归、白芍、苯巴比妥、氟尿嘧啶、二氧六环、甲基肼。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精华制药,002349,精华制药股票,精华制药股票老虎,精华制药股票老虎国际,精华制药行情,精华制药股票行情,精华制药股价,精华制药股市,精华制药股票价格,精华制药股票交易,精华制药股票购买,精华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精华制药(002349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精华制药(002349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}